BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25944395)

  • 1. Dosimetric comparison of brachyablation and stereotactic ablative body radiotherapy in the treatment of liver metastasis.
    Pennington JD; Park SJ; Abgaryan N; Banerjee R; Lee PP; Loh C; Lee E; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(4):537-42. PubMed ID: 25944395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
    Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case.
    Esposito M; Maggi G; Marino C; Bottalico L; Cagni E; Carbonini C; Casale M; Clemente S; D'Alesio V; Fedele D; Giglioli FR; Landoni V; Martinotti A; Nigro R; Strigari L; Villaggi E; Mancosu P
    Phys Med; 2016 Jan; 32(1):277-83. PubMed ID: 26498378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical appraisal of volumetric modulated arc therapy in stereotactic body radiation therapy for metastases to abdominal lymph nodes.
    Bignardi M; Cozzi L; Fogliata A; Lattuada P; Mancosu P; Navarria P; Urso G; Vigorito S; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1570-7. PubMed ID: 19880261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity.
    Goldsmith C; Plowman PN; Green MM; Dale RG; Price PM
    Radiat Oncol; 2018 Oct; 13(1):204. PubMed ID: 30340643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: optimal isodose line fitting to the planning target volume.
    Oku Y; Takeda A; Sanuki N; Sudo Y; Oooka Y; Aoki Y; Shimouchi Y; Nishina R; Nomura K; Eriguchi T; Kunieda E
    Pract Radiat Oncol; 2014; 4(1):e7-e13. PubMed ID: 24621435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated image-guided breath-hold SABR (stereotactic ablative body radiotherapy) of liver metastases--clinical results.
    Boda-Heggemann J; Dinter D; Weiss C; Frauenfeld A; Siebenlist K; Attenberger U; Ottstadt M; Schneider F; Hofheinz RD; Wenz F; Lohr F
    Radiat Oncol; 2012 Jun; 7():92. PubMed ID: 22710033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
    Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
    Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis between interstitial brachytherapy and stereotactic body irradiation for local ablation in liver malignancies.
    Hass P; Mohnike K; Kropf S; Brunner TB; Walke M; Albers D; Petersen C; Damm R; Walter F; Ricke J; Powerski M; Corradini S
    Brachytherapy; 2019; 18(6):823-828. PubMed ID: 31522972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.
    Wang CJ; Christie A; Lin MH; Jung M; Weix D; Huelsmann L; Kuhn K; Meyer J; Desai N; Kim DWN; Pedrosa I; Margulis V; Cadeddu J; Sagalowsky A; Gahan J; Laine A; Xie XJ; Choy H; Brugarolas J; Timmerman R; Hannan R
    Int J Radiat Oncol Biol Phys; 2017 May; 98(1):91-100. PubMed ID: 28587057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Hepatic Toxicity in Primary and Metastatic Liver Cancers after Stereotactic Ablative Radiotherapy Using 3 Fractions.
    Bae SH; Kim MS; Jang WI; Cho CK; Yoo HJ; Kim KB; Han CJ; Park SC; Lee DH
    J Korean Med Sci; 2015 Aug; 30(8):1055-61. PubMed ID: 26240482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.
    Li R; Zhang Y; Yuan Y; Lin Q; Dai J; Xu R; Hu X; Han M
    PLoS One; 2017; 12(11):e0187390. PubMed ID: 29121047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of liver tumour radiotherapy in all respiratory phases and in one phase using 4DCT.
    Gabryś D; Kulik R; Trela K; Ślosarek K
    Radiother Oncol; 2011 Sep; 100(3):360-4. PubMed ID: 21974916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of removing respiratory motion during liver SABR.
    Gargett M; Haddad C; Kneebone A; Booth JT; Hardcastle N
    Radiat Oncol; 2019 Jun; 14(1):93. PubMed ID: 31159840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric Consequences of 3D Versus 4D PET/CT for Target Delineation of Lung Stereotactic Radiotherapy.
    Siva S; Chesson B; Callahan JW; Hardcastle N; Crawford L; Antippa P; Wright G; MacManus MP; Hicks RJ; Kron T; Ball DL
    J Thorac Oncol; 2015 Jul; 10(7):1112-5. PubMed ID: 26134229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.
    Eriguchi T; Takeda A; Oku Y; Ishikura S; Kimura T; Ozawa S; Nakashima T; Matsuo Y; Nakamura M; Matsumoto Y; Yamazaki S; Sanuki N; Ito Y
    Radiat Oncol; 2013 May; 8():113. PubMed ID: 23641879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative planning study for lung SABR between tri-Co-60 magnetic resonance image guided radiation therapy system and volumetric modulated arc therapy.
    Park JM; Park SY; Kim HJ; Wu HG; Carlson J; Kim JI
    Radiother Oncol; 2016 Aug; 120(2):279-85. PubMed ID: 27401404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.